Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Consensus Rating of “Hold” from Analysts
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) has received a consensus rating of “Hold” from the five ratings firms that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among brokerages […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) has received a consensus rating of “Hold” from the five ratings firms that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among brokerages […]
